Integrated Diagnostics Holdings Plc

Integrated Diagnostics Holdings Plc

0.43
EUR
0.00
(0.00%)
0.02EPS
11.40P/E
181.20MMarket Cap

Total Valuation

EUR

As of June 30, 2024, Integrated Diagnostics Holdings Plc carries a market capitalization of 181.20M, placing it among publicly traded companies globally. Its enterprise value stands at 195.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap181.20M
Enterprise Value195.69M

Important Dates

Integrated Diagnostics Holdings Plc's next confirmed earnings release is scheduled for November 16, 2026.

Earnings Date11/16/2026

Share Statistics

As of June 30, 2024, Integrated Diagnostics Holdings Plc has 600.00M shares outstanding.

Shares Outstanding600.00M

Valuation Ratios

As of June 30, 2024, Integrated Diagnostics Holdings Plc trades at a trailing price-to-earnings ratio of 11.40. The price-to-sales ratio is 1.96, and the price-to-book ratio stands at 3.34.

PE Ratio11.40
PS Ratio1.96
PB Ratio3.34
P/TBV Ratio9.29
P/FCF Ratio15.34
P/OCF Ratio11.11

Enterprise Valuation

As of June 30, 2024, Integrated Diagnostics Holdings Plc trades at an EV/EBITDA multiple of 7.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 11.09 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Integrated Diagnostics Holdings Plc trades at an EV/FCF ratio of 14.24, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 195.69M versus a market cap of 181.20M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.12
EV / EBITDA7.48
EV / EBIT11.09
EV / FCF14.24

Financial Position

As of June 30, 2024, Integrated Diagnostics Holdings Plc maintains a current ratio of 1.59, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.86, indicating elevated leverage, while an interest coverage ratio of 8.98 demonstrates adequate ability to service its debt obligations.

Current Ratio1.59
Quick Ratio0.76
Debt / Equity35.86
Debt / EBITDA0.95
Interest Coverage8.98

Financial Efficiency

EUR

Over the twelve months ended June 30, 2024, Integrated Diagnostics Holdings Plc posted a return on equity (ROE) of 31.08, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 14.92 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 13.36, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 25.59, useful for judging operating efficiency across full business cycles. The company generates approximately 16,975.27 in revenue per employee across its workforce of 5,440.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.18 indicates how many times Integrated Diagnostics Holdings Plc sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)31.08
Return on Assets (ROA)13.36
Return on Invested Capital (ROIC)14.92
Return on Capital Employed (ROCE)25.59
Revenue Per Employee16,975.27
Employee Count5,440.00
Inventory Turnover7.18

Taxes

EUR

Over the twelve months ended June 30, 2024, Integrated Diagnostics Holdings Plc recorded 7.35M in income tax expense. That works out to an effective tax rate of 33.88, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 21.69M, leaving 15.89M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax7.35M
Effective Tax Rate33.88

Stock Price Statistics

EUR

As of the close on November 17, 2026, Integrated Diagnostics Holdings Plc's stock has declined approximately 30.65% over the past 52 weeks. The 50-day moving average sits at 0.43, while the 200-day moving average is 0.46.

52-Week Price Change-30.65%
50-Day Moving Average0.43
200-Day Moving Average0.46

Income Statement

EUR

Over the twelve months ended June 30, 2024, Integrated Diagnostics Holdings Plc generated 92.35M in revenue and converted that into 15.89M in net income, yielding earnings per share of 0.02. EBITDA reached 26.16M, while operating income came in at 18.55M.

Revenue92.35M
Gross Profit34.84M
Operating Income18.55M
Pretax Income21.69M
Net Income15.89M
EBITDA26.16M
EBIT17.65M
Earnings Per Share (EPS)0.02

Balance Sheet

EUR

As of June 30, 2024, Integrated Diagnostics Holdings Plc holds 25.17M in cash and equivalents against 24.77M in total debt, resulting in a net debt position of -13.68M. Total book value stands at 54.19M, with working capital of 19.63M providing operational flexibility.

Cash & Cash Equivalents25.17M
Total Debt24.77M
Net Debt-13.68M
Equity (Book Value)54.19M
Book Value Per Share0.09
Working Capital19.63M

Cash Flow

EUR

Integrated Diagnostics Holdings Plc produced 16.32M in operating cash flow over the twelve months ended June 30, 2024. After subtracting -4.50M in capital expenditures, free cash flow totaled 11.81M - equivalent to 0.02 per share.

Operating Cash Flow16.32M
Capital Expenditures-4.50M
Free Cash Flow11.81M
FCF Per Share0.02

Margins

Over the twelve months ended June 30, 2024, Integrated Diagnostics Holdings Plc posted a gross margin of 37.72, reflecting its pricing power and cost economics. The operating margin of 20.08 and net profit margin of 17.21 provide insight into operational efficiency.

Gross Margin37.72
Operating Margin20.08
Pretax Margin23.49
Profit Margin17.21
EBITDA Margin28.33

Dividends & Yields

These figures cover the twelve months ended June 30, 2024. Free cash flow yield stands at 6.52, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.62, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Integrated Diagnostics Holdings Plc shareholders.

Shareholder Yield2.62
FCF Yield6.52

Stock Splits

Integrated Diagnostics Holdings Plc's most recent stock split took place on December 24, 2020 with a 1:4 split ratio.

Last Split Date12/24/2020
Split Ratio1:4

Scores

As of June 30, 2024, Integrated Diagnostics Holdings Plc has an Altman Z-Score of 4.07, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.07